Cargando…

Prognostic impact of leukocyte counts before and during radiotherapy for oropharyngeal cancer

INTRODUCTION: Peripheral blood count components are accessible and evidently predictive in other cancers but have not been explored in oropharyngeal carcinoma. We examine if there is an association between the use of intensity-modulated radiotherapy (IMRT) or intensity-modulated proton therapy (IMPT...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jensen, Garrett L., Blanchard, Pierre, Gunn, G. Brandon, Garden, Adam S., David Fuller, C., Sturgis, Erich M., Gillison, Maura L., Phan, Jack, Morrison, William H., Rosenthal, David I., Frank, Steven J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862666/ https://www.ncbi.nlm.nih.gov/pubmed/29594226 http://dx.doi.org/10.1016/j.ctro.2017.09.008

Ejemplares similares

Prognostic significance of pre-treatment neutrophil-to-lymphocyte ratio (NLR) in patients with oropharyngeal cancer treated with radiotherapy
por: Ng, Sweet Ping, et al.
Publicado: (2020)

Proton Beam Therapy for Head and Neck Carcinoma of Unknown Primary: Toxicity and Quality of Life
por: Sherry, Alexander D., et al.
Publicado: (2021)

Patient-Reported Outcomes after Intensity-Modulated Proton Therapy for Oropharynx Cancer
por: Bahig, Houda, et al.
Publicado: (2021)

Outcomes and patterns of care of patients with locally advanced oropharyngeal carcinoma treated in the early 21(st) century
por: Garden, Adam S, et al.
Publicado: (2013)

Association of Risk Factors With Patient-Reported Voice and Speech Symptoms Among Long-term Survivors of Oropharyngeal Cancer
por: Aggarwal, Puja, et al.
Publicado: (2021)

Tobacco exposure as a major modifier of oncologic outcomes in human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma
por: Elhalawani, Hesham, et al.
Publicado: (2020)

Prospective observational evaluation of radiation-induced late taste impairment kinetics in oropharyngeal cancer patients: Potential for improvement over time?
por: Stieb, Sonja, et al.
Publicado: (2020)

Proton Therapy for HPV-Associated Oropharyngeal Cancers of the Head and Neck: a De-Intensification Strategy
por: Taku, Nicolette, et al.
Publicado: (2021)

Genetic susceptibility to patient-reported xerostomia among long-term oropharyngeal cancer survivors
por: Aggarwal, Puja, et al.
Publicado: (2022)

Risk of second primary malignancies in head and neck cancer patients treated with definitive radiotherapy
por: Ng, Sweet Ping, et al.
Publicado: (2019)

Patterns of Failure After Intensity Modulated Radiation Therapy in Head and Neck Squamous Cell Carcinoma of Unknown Primary: Implication of Elective Nodal and Mucosal Dose Coverage
por: Kamal, Mona, et al.
Publicado: (2020)

The impact of tongue-deviating and tongue-depressing oral stents on long-term radiation-associated symptoms in oropharyngeal cancer survivors
por: Stieb, Sonja, et al.
Publicado: (2020)

Association of hearing loss and tinnitus symptoms with health‐related quality of life among long‐term oropharyngeal cancer survivors
por: Aggarwal, Puja, et al.
Publicado: (2022)

Activity-Based Costing of Intensity-Modulated Proton versus Photon Therapy for Oropharyngeal Cancer
por: Thaker, Nikhil G., et al.
Publicado: (2021)

Prospective in silico study of the feasibility and dosimetric advantages of MRI-guided dose adaptation for human papillomavirus positive oropharyngeal cancer patients compared with standard IMRT
por: Mohamed, Abdallah S.R., et al.
Publicado: (2018)

Defining the dose‐volume criteria for laryngeal sparing in locally advanced oropharyngeal cancer utilizing split‐field IMRT, whole‐field IMRT and VMAT
por: Wilke, Christopher, et al.
Publicado: (2020)

Significance of microRNA-related variants in susceptibility to recurrence of oropharyngeal cancer patients after definitive radiotherapy
por: Chen, Xingming, et al.
Publicado: (2016)

Design and fabrication of a 3D–printed oral stent for head and neck radiotherapy from routine diagnostic imaging
por: Wilke, Christopher T., et al.
Publicado: (2017)

Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients ≥65 years old
por: Eraj, Salman A., et al.
Publicado: (2017)

Correction to: Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients ≥65 years old
por: Eraj, Salman A., et al.
Publicado: (2017)

Hypothyroidism following Radiotherapy for Head and Neck Cancer: A Systematic Review of the Literature and Opportunities to Improve the Therapeutic Ratio
por: Rooney, Michael K., et al.
Publicado: (2023)

Work Outcomes after Intensity-Modulated Proton Therapy (IMPT) versus Intensity-Modulated Photon Therapy (IMRT) for Oropharyngeal Cancer
por: Smith, Grace L., et al.
Publicado: (2021)

Quick Leukocyte Nucleus Segmentation in Leukocyte Counting
por: Wang, Yapin, et al.
Publicado: (2019)

The Modifying Effect of a Functional Variant at the miRNA Binding Site in E2F1 Gene on Recurrence of Oropharyngeal Cancer Patients with Definitive Radiotherapy
por: Zhang, Hua, et al.
Publicado: (2018)

Pretreatment Lymphocyte Count Predicts Benefit From Concurrent Chemotherapy With Radiotherapy in Oropharyngeal Cancer
por: Price, James M., et al.
Publicado: (2022)

Concordance of oral HPV prevalence between patients with oropharyngeal cancer and their partners
por: Tsao, Anne S., et al.
Publicado: (2016)

(18)FDG positron emission tomography mining for metabolic imaging biomarkers of radiation-induced xerostomia in patients with oropharyngeal cancer
por: Elhalawani, Hesham, et al.
Publicado: (2021)

Creating customized oral stents for head and neck radiotherapy using 3D scanning and printing
por: Zaid, Mohamed, et al.
Publicado: (2019)

Proton Image-guided Radiation Assignment for Therapeutic Escalation via Selection of locally advanced head and neck cancer patients [PIRATES]: A Phase I safety and feasibility trial of MRI-guided adaptive particle radiotherapy
por: van Dijk, Lisanne V., et al.
Publicado: (2021)

A functional variant at miRNA-122 binding site in IL-1α 3′ UTR predicts risk of recurrence in patients with oropharyngeal cancer
por: Wang, Chengyuan, et al.
Publicado: (2016)

Optimizing laryngeal sparing with intensity modulated radiotherapy or volumetric modulated arc therapy for unilateral tonsil cancer
por: Moreno, Amy C., et al.
Publicado: (2019)

The Stability of Blood Gas Parameters Depends on Leukocyte Counts
por: Vaudran, Lucie, et al.
Publicado: (2021)

Alterations in oral bacterial communities are associated with risk factors for oral and oropharyngeal cancer
por: Börnigen, Daniela, et al.
Publicado: (2017)

Association of Combined p73 and p53 Genetic Variants with Tumor HPV16-Positive Oropharyngeal Cancer
por: Wang, Zhongqiu, et al.
Publicado: (2012)

Blood Leukocyte Counts in Alzheimer Disease
por: Luo, Jiao, et al.
Publicado: (2022)

An economic and disease transmission model of human papillomavirus and oropharyngeal cancer in Texas
por: Zhong, Chengxue, et al.
Publicado: (2021)

Factors associated with complex oral treatment device usage in patients with head and neck cancer
por: Palasi, Stephen, et al.
Publicado: (2021)

Radiation-Induced Hypothyroidism After Radical Intensity Modulated Radiation Therapy for Oropharyngeal Carcinoma
por: Kamal, Mona, et al.
Publicado: (2019)

Estimation of daily interfractional larynx residual setup error after isocentric alignment for head and neck radiotherapy: quality assurance implications for target volume and organs‐at‐risk margination using daily CT on‐rails imaging
por: Baron, Charles A., et al.
Publicado: (2014)

Complete Surgical Resection Following Neoadjuvant Dabrafenib Plus Trametinib in BRAF(V600E)-Mutated Anaplastic Thyroid Carcinoma
por: Wang, Jennifer R., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bidak07iqc2bcmdf4e1mt2q98m